Lior Carmon
Founder
Your CSV is on the way
We’ve sent your CSV file to email@email.com
Claimed by
owner Add to list
CureTech
Former names:
Cancer Immunotherapy
Stealth Mode
Feb 2019 ceased to operate
CureTech
CureTech Overview
CureTech is a biotechnology company developing broad-spectrum, immune-modulating products for the treatment and control of cancer. Its product line includes antibodies and peptide-based vaccines designed to modulate the immune response, allowing it to exert its anti-cancer activity in an effective manner.
CureTech's lead humanized antibody product, pidilizumab (CT-011), is in Phase II clinical testing. Pidilizumab has shown promising results in attenuating tumor growth and eliminating tumor metastases in a variety of model systems.
Several patents and pending patent applications worldwide protect the company's products. A licensing agreement for further development and commercialization of pidilizumab was signed with Medivation in 2014. In 2018, InSight Innovations acquired CureTech.
CureTech's lead humanized antibody product, pidilizumab (CT-011), is in Phase II clinical testing. Pidilizumab has shown promising results in attenuating tumor growth and eliminating tumor metastases in a variety of model systems.
Several patents and pending patent applications worldwide protect the company's products. A licensing agreement for further development and commercialization of pidilizumab was signed with Medivation in 2014. In 2018, InSight Innovations acquired CureTech.
Cumulative Funding Raised Over Time ($)
Employees Over Time
CureTech Climate Tech relevance
null
No Data, yet.
Sorry, no content found under this section.
Feb 3, 2020
www.calcalistech.com
CureTech's Cancer-Fighting Dreams End With Insolvency
#Investment #Acquisition #Layoffs
Jul 5, 2018
www.calcalistech.com
Cost-Cutting at CureTech Following Cancellation of Acquisition Deal with Insight
#Acquisition
Mar 28, 2018
www.globes.co.il
InSight Innovations buys CureTech for up to $550m
#Acquisition
Oct 1, 2017
www.globes.co.il
CureTech buys back cancer drug from Pfizer for $20m
#Acquisition #Layoffs
Dec 21, 2014
www.globes.co.il
Medivation takes up $335m Curetech licensing option
#Partners #Investment
Companies you might be interested in
Driven by Finder AI
Related Content
Lists. Maps. Reports
Team Members
LC
Contact Team
Affiliated Organizations
(null)Web & social links
http://curetechbio.com
Locations
Israel
Derech Menachem Begin 132, Tel Aviv-Yafo, Israel
Offices Abroad
Photos & videos
(2)No Data, yet.
Sorry, no content found under this section.
CureTech Business
Sector
Primary:
Target Customer
Core Technology
Use Cases
(0)Tech Community Involvement
(0)CureTech Financials
Cumulative Funding Raised Over Time ($)
No Data, yet.
Sorry, no content found under this section.
Public Offerings & Exits
Private Equity Funding
Undisclosed Round
$4M
Sep 2013
1
Investors
$4M
Non-Equity Funding
Mergers and Acquisitions
CureTech Lifecycle
Cumulative Funding Raised Over Time ($)
Timeline
Employees Over Time
News Over Time
No Data, yet.
Sorry, no content found under this section.
Closing Event
Feb 2019
Undisclosed Round
$4M
Sep 2013
1
Investors
$4M
CureTech News
News Over Time
No Data, yet.
Sorry, no content found under this section.
News Articles
Feb 3, 2020
www.calcalistech.com
CureTech's Cancer-Fighting Dreams End With Insolvency
#Investment #Acquisition #Layoffs
Jul 5, 2018
www.calcalistech.com
Cost-Cutting at CureTech Following Cancellation of Acquisition Deal with Insight
#Acquisition
Mar 28, 2018
www.globes.co.il
InSight Innovations buys CureTech for up to $550m
#Acquisition
Oct 1, 2017
www.globes.co.il
CureTech buys back cancer drug from Pfizer for $20m
#Acquisition #Layoffs
Dec 21, 2014
www.globes.co.il
Medivation takes up $335m Curetech licensing option
#Partners #Investment
Related Content
CureTech Team
No Data, yet.
Sorry, no content found under this section.
Employees Over Time
Companies you might be interested in
Driven by Finder AI
CureTech Internal
Create note
Notes
(undefined)
Filter notes
Content Writer
undefined
BI Verification
undefined
Phone Number
undefined
Israel Register ID
undefined
Confidence Score
undefined
Missing Fields
undefined
Profile Creator
undefined
Profile Update
undefined
undefined
Access Comprehensive Financial Analytics
Create a free account to:
- Explore detailed financial analytics.
- Track company growth and size.
- Connect with company team members.
I already have access,
I already have access,